;

From bench to bedside improving outcomes for patients diagnosed with sarcoma.

Spotlight

“Given the rarity of sarcoma and the many subtypes, no single institution has sufficient patient resources for timely accrual and adequate statistical power to complete trials that will yield meaningful results for a variety of sarcoma.”

Read more

Jonathan Fletcher, MD
SARC Chief Scientific Officer
SARC @ ASCO 2022

SARC MEETING Recap

Over 200 attend the SARC Semiannual Meeting at ASCO in Chicago.

  • Wednesday
  • Nov 16
  • 2022


WHAT ARE SARCOMAS?

Sarcomas are uncommon and there are many different types — experts have identified more than 80 different forms — leading to significant diagnostic and therapeutic challenges. Sarcomas represent 15 to 20% of childhood cancers and 1% of adult cancers.

LEARN MORE

young child sarcoma patient

WHAT DOES SARC DO?

Founded in 2003 as a non-profit cancer research organization, SARC directly develops, sponsors, and manages research projects for pediatric and adult sarcomas. We lead domestic and international collaborative discovery, translational research, and clinical trials.

LEARN MORE

Microscope Pink

WHO PARTNERS WITH SARC?

We collaborate with the scientific research community, partner with pharmaceutical and biotech companies, and inform patients and caregivers about our work. Attend our bi-annual meetings to learn more about the latest developments in sarcoma research.

LEARN MORE

Back to top